Neoadjuvant chemotherapy versus neoadjuvant hormonal therapy in postmenopausal women with ER-positive, HER2/neu negative locally advanced breast cancer.
Tadeu Ambros(University of Miami), Judith Hurley(University of Miami), Carmen Gomez Fernandez(University of Miami), José C. Villasboas(Mayo Clinic), Victoria Sujoy(University of Miami), Isildinha M. Reis(University of Miami), Dilprit Bagga(University of California, Los Angeles), Clifford Blieden(University of Miami), Kunal Saigal(University of Miami), Jean L. Wright(University of North Carolina at Chapel Hill)
Cited by 1
Related Papers
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline
|Practical Radiation Oncology|2018|615
Effectiveness of early orthodontic treatment with the twin-block appliance: A multicenter, randomized, controlled trial. Part 1: Dental and skeletal effects
|American Journal of Orthodontics and Dentofacial Orthopedics|2003|374
Effectiveness of treatment for class II malocclusion with the herbst or twin-block appliances: a randomized, controlled trial
|American Journal of Orthodontics and Dentofacial Orthopedics|2003|275
Effectiveness of early orthodontic treatment with the twin-block appliance: a multicenter, randomized, controlled trial. Part 2: psychosocial effects
|American Journal of Orthodontics and Dentofacial Orthopedics|2003|191